Jill Drury Pharm.D., Bcop, MBA
About Jill Drury Pharm.D., Bcop, MBA
Jill Drury, Pharm.D., BCOP, MBA, serves as the Worldwide Oncology Medical Director at Bristol-Myers Squibb in Princeton, New Jersey. She has extensive experience in oncology and clinical pharmacy, having previously worked at Pfizer, AstraZeneca, BioScrip, Rush Medical College, Northwestern Memorial Hospital, and CVS Pharmacy.
Current Title and Role at Bristol-Myers Squibb
Jill Drury serves as the Worldwide Oncology Medical Director at Bristol-Myers Squibb, located in Princeton, New Jersey, United States. In this role, she focuses on integrating clinical research with business rationales, supporting product development, and ensuring shareholder satisfaction.
Previous Work Experience at Pfizer
Before her current role, Jill Drury was the Medical Director for Oncology in North America at Pfizer from 2014 to 2019. Her responsibilities included managing high volume projects and generating competitive data to strengthen the company's oncology portfolio.
Regional Oncology Roles at AstraZeneca and BioScrip
Jill Drury also held positions as the Regional Oncology Scientific Manager for the Midwest Region at AstraZeneca from 2012 to 2014 and as the Regional Clinical Oncology Pharmacist and Hematology Director for the Midwest Region at BioScrip, Inc. from 2011 to 2014. In these roles, she was known for implementing constructive process improvements and fostering diverse group collaboration.
Early Career in Clinical Pharmacy
Jill Drury began her career as a Clinical Oncology Pharmacy Specialist at Rush Medical College of Rush University Medical Center from 2009 to 2011 and as a Clinical Pharmacist at Northwestern Memorial Hospital from 2008 to 2009. Additionally, she served as the Clinical Pharmacist Manager and Regional Trainer for CVS Pharmacy from 2007 to 2013.
Educational Background and Certifications
Jill Drury holds a Doctor of Pharmacy (Pharm.D.) degree from Midwestern University, College of Pharmacy and a Master of Business Administration (MBA) from the University of Michigan - Stephen M. Ross School of Business. She is also a Board Certified Oncology Pharmacist (BCOP) and has a Master’s in Health Administration (MHA) from New York University.